Candesant Biomedical
PrivateLast Round
Series B
Jun 6, 2023
Total Funding Raised
$44.13M
Company Overview
Candesant Biomedical is a medical device company that specializes in developing a proprietary device aimed at treating hyperhidrosis by targeting and inactivating overactive sweat glands to help reduce sweating and prevent bacterial growth.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Fashion & Beauty
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Candesant Biomedical Comps
Public and private peers based on sector, stage, and business model.
Candesant Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 6, 2023 | ||||
| Series A | Feb 14, 2020 |
Candesant Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KCK MedTech | Series B |
| Astia Fund | Series B |
| Polaris Partners | Series B |
| Correlation Ventures | Series B |
Candesant Biomedical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Candesant Biomedical's valuation, stock price, and market status.
